Unilife Wins Supply Contract With Nation's Largest Healthcare Alliance

Unilife Corporation recently announced it has been awarded a 2-year contract by Premier Purchasing Partners, L.P., the group purchasing enterprise of the Premier healthcare alliance, for the supply of its Unitract 1-mL safety syringes.Premier, Inc. is the nation’s largest healthcare alliance, helping to improve performance and providing group contracting to more than 2,500 US hospitals and over 76,000 healthcare sites nationwide.

“Our Unitract 1-mL safety syringes, which are designed for use when drawing medication from a vial or ampoule, can provide optimal protection to healthcare workers and others at risk of infection from needlestick injuries. Unitract represents the first and only known range of insulin and tuberculin syringes with automatic, operator-controlled needle retraction features that are fully integrated within the syringe. We are delighted to have signed our first Group Purchasing Organization (GPO) contract with Premier for the sale of our Unitract 1-mL syringes to US healthcare facilities. In addition to being one of the largest GPOs in the US, Premier is also a leading national advocate for injection safety. Despite the widespread conversion of US healthcare facilities to the mandatory use of needlestick prevention products, healthcare workers continue to remain at risk of harm from many types of conventional safety syringe technologies. We look forward to supporting Premier and its members to enhance the level of protection offered to US healthcare workers.”

The Unitract range of 1-mL insulin and tuberculin syringes utilize a unique combination of automatic and fully integrated safety features to provide optimal protection to healthcare workers and patients at risk of needlestick injuries when injecting a drug supplied in a vial or ampoule. An audible, tactile click signals the automatic (passive) activation of the needle retraction mechanism upon the full injection of the dose. Operators can control the speed at which the needle is withdrawn directly from the body into the barrel of the syringe by relieving thumb or finger pressure on the plunger. The plunger is then locked to prevent needle re-exposure, tampering, or device reuse. Unitract 1-mL syringes are manufactured at Unilife’s FDA-registered manufacturing facilities in York, PA.

Unilife Corporation is a US-based developer, manufacturer, and supplier of advanced drug delivery systems with state-of-the-art facilities in Pennsylvania. Established in 2002, Unilife works with pharmaceutical and biotechnology companies seeking innovative devices for use with their parenteral drugs and vaccines.